Loading chat...
NY A04798
Bill
Status
2/23/2023
Primary Sponsor
Gary Pretlow
Click for details
AI Summary
-
Requires all individual health insurance policies providing hospital, surgical, or medical care coverage to include coverage for human leukocyte antigen (HLA) testing for A, B, and DR antigens used in bone marrow tissue typing.
-
Mandates group and blanket health insurance policies delivered in New York to provide the same HLA testing coverage, with an exception for policies covering employees in multiple states or subject to multi-state collective bargaining.
-
Applies the HLA testing coverage requirement to medical expense indemnity corporations, hospital service corporations, and health service corporations, with the same multi-state employment exception.
-
Takes effect January 1st following enactment and applies to all policies and contracts issued, renewed, modified, altered, or amended on or after the effective date.
Legislative Description
Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens, for utilization in tissue typing for bone marrow testing.
Last Action
referred to insurance
1/3/2024